Injectable Pens Market Report

Injectable Pens Market Analysis By Product, By Dosage, By Application And Segment Forecasts, 2018 To 2025

  • Published Date: ---
  • Base Year for Estimate:
  • Report ID: GVR5265
  • Format: Electronic (PDF)
  • Historical Data:
  • Number of Pages: 0

Injectable Pens Market is anticipated to exhibit lucrative growth over the forecast period as a consequence of increasing incidences of diseases such as diabetes and arthritis, increasing geographical reach by market players, high demand for safer drug delivery devices and advanced drug delivery devices are the factors that are expected to drive the market during the forecast period.

Conventional method of injecting drugs such as syringes and vials are rapidly being replaced by various new methods such as pen devices and injection pumps that are more convenient and flexible. Injectable pens has significant applications in management of various chronic diseases majorly- diabetes, arthritis, osteoporosis, growth hormone deficiency, and arthritis. Increasing prevalence of these devices has a direct impact on injectable pens demand.

Most of the pen injectors available today are reusable. These pens require replacement of only needles and cartridges and they can be used for longer time making them cost effective. Additionally, high demand for measures to reduce needlestick injuries and presence of wide network of distribution of international players are few factors attributing towards the growth of the market.

Some of the key players in the market are Owen Mumford Ltd., Eli Lilly and Company, GlaxoSmithKline plc, Mylan N.V., AstraZeneca, Novo Nordisk, Sandoz Inc, and Sanofi.

Key players are adopting strategies such as mergers & acquisitions and product launch & enter into partnerships to strengthen their position in the market. For instance, in October 2017, Eli Lilly and Company announced the launch of Humalog Junior KwikPen in the U.S. for the treatment of diabetes.

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,950
Multi User (2-5) - $5,950
Enterprise Access - $7,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified